« Back
Home /
Bucillamine

Bucillamine

Manufacturer	TargetMol
Category	Molecule
Type	Molecules
Specific against	other
Amount	1g
Item no.	TMO-T21334-1g
Approximate Leadtime	1-2 Weeks
eClass 6.1	32169090
eClass 9.0	32169090
Available
SMILES	O=C(O)C(NC(C(C)(S)C)=O)CS
formula	C7H13NO3S2
MolWt	223.31
Bioactivity	Bucillamine is an antirheumatic agent. Its activity is mediated by the two thiol groups in the molecule. Research done in USA showed positive transplant preservation properties.
Reference	Matsuno H, Okada M, Sakai Y, Abe C, Katayama K, Sagawa A, Yamasaki K, Kondo M, Funahashi K, Matsubara T. The Usefulness of a New Triple Combination Treatment Utilizing methotrexate, salazosulfapyridine, and bucillamine in Rheumatoid Arthritis. Mod Rheumatol. 2015 Jun 8:1-20. [Epub ahead of print] PubMed PMID: 26052803.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Request Data Sheet

TMO-T21334-1g-datasheet.pdf

TMO-T21334-1g-safety-datasheet.pdf